Madison, WI
Madison Concourse Hotel
August 27-28, 2026

Advancing Precision Cancer Care Through Multidisciplinary Collaboration

Madison, WI
August 27-28, 2026

Advancing the Diagnostic-to-Treatment Continuum in Cancer Care –
Madison

Advancing science through collaboration and shared purpose

Madison is home to leading research institutions and clinical innovators advancing cancer discovery, molecular medicine, and precision oncology across the Midwest. The Advancing Precision Oncology and Advancing Pathology Education meeting will bring together pathologists, oncologists, translational researchers, and healthcare professionals for a multidisciplinary program focused on connecting diagnostic insight with real-world therapeutic decision-making.

The program will be co-chaired by Razelle Kurzrock, MD, FACP, Associate Director of Clinical Research at the Medical College of Wisconsin Cancer Center, and Jeremy Kratz, MD, Assistant Professor in the Division of Hematology, Medical Oncology and Palliative Care at the University of Wisconsin School of Medicine and Public Health, physician-scientist at the UW Carbone Cancer Center, and investigator with UW’s Center for Precision Medicine.

Dr. Kurzrock is a globally recognized leader in precision oncology, biomarker-driven clinical trials, rare cancers research, and experimental therapeutics. She has led more than 100 clinical trials and has been instrumental in advancing personalized treatment strategies that match patients to therapies based on the molecular profile of their disease.

Dr. Kratz’s clinical and research interests focus on hepatobiliary and pancreatic cancers, with an emphasis on patient-derived cancer models, molecular profiling, targeted therapeutics, and mechanisms of treatment resistance. Through his work with the Center for Precision Medicine and UW Carbone Cancer Center, he helps advance translational strategies that connect molecular insights with precision cancer care.

Through dialogue across pathology, oncology, and translational science, this meeting will highlight emerging discoveries and practical strategies that support precision oncology in everyday clinical practice. Attendees will gain actionable insights and collaborative perspectives to help advance cancer care throughout the region.

Continuing education credits, including CME/CE and MOC, are planned for this activity.

Agenda

EVENT PARTNERS

August 27, 2026
7:45 AM	Registration & Check-in
8:25 AM	Welcome and Introductions
8:30 AM	Lung
8:55 AM	MCW Update on Precision Targeting of SCLC
9:20 AM	Pathology Perspectives in Lung Cancer
9:45 AM	Targeted Therapeutics in Lung Cancer Panel
10:00 AM	Exhibits/Breakfast
10:30AM	Non-CME Session
10:50 AM	Exhibits/Networking
11:20 AM	Immunotherapy of Rare Cancers: the NCI SWOG DART Experience
11:50 AM	Precision Targeting in Lung Cancer
12:20 PM	Bispecific Cancer Therapies – Hitting the Target in Small Cell
12:50 PM	Colorectal Cancer: Biomarkers & Methodologies Stanley Hamilton, MD
1:20 PM	Colorectal Cancer Updates
1:50 PM	Exhibits/Lunch
2:20 PM	Non-CME Session
3:00 PM	Exhibits/Break
3:30 PM	Precision Oncology in the Community Setting – Panel
4:15 PM	Precision Oncology Impact on Patient Partnerships
4:45 PM	Patient Narrative
5:15 PM	Day 1 Round Up Panel
5:45 PM	Adjourn

Learning Objectives

Integrate evidence-based advances from both pathology and oncology to enhance biomarker testing, diagnosis, and treatment planning for solid tumors and hematologic malignancies.
Apply multidisciplinary insights and new clinical data to improve therapeutic decision-making and patient outcomes across diverse practice settings.

Accreditation Information | TBD CE/CME Credits

Additional Information Coming Soon

August 28, 2026
9:00 AM	Registration & Check-in
9:25 AM	Welcome & Day One Wrap Up
9:30 AM	Precision Targeting of Rare Cancers Based on Multiple Omics
10:00 AM	Chronic Lymphocytic Leukemia
10:30 AM	Breakfast/Exhibits
10:50 AM	Non-CME Session
11:10 AM	Exhibits/Networking
11:40 PM	Breast Cancer Debate: Tissue vs. ctDNA – When, Where, Why, How?
12:10 PM	Receptor Tyrosine Kinase Targeting in Breast Cancer
12:40 PM	Emerging Precision Targets in Hematological Malignancies
1:10 PM	Next-Generation Genomic Tools
1:40 PM	Panel Wrap Up
2:00 PM	Break/Exhibits

Speakers

CHAIR
Razelle Kurzrock, MD, FACP
Chief Medical Officer
WIN Consortium
View Profile
Chief Medical Officer, WIN Consortium
Professor of Medicine, Associate Director, Chair of Precision Oncology, Clinical Research, MCW Cancer Center and Linda T. & John A. Mellowes Center for Genomic Sciences and Precision Medicine
Founding Director, Michels Rare Cancers Research Laboratories, Froedtert & Medical College of Wisconsin
Adjunct Professor, University of Nebraska
Razelle Kurzrock, MD is a world-renowned physician-scientist leader in precision medicine as well as in the development of novel therapeutics in the field of oncology. She is recognized for founding, developing and chairing one of the largest Phase 1 clinical trial departments globally while at the University of Texas MD Anderson Cancer Center; the central theme of the department was a personalized medicine strategy. She is also one of the pioneering trialists of the WINTHER precision medicine trial focusing, for the first time, on transcriptomics in addition to genomics. This trial was the signature study of the WIN international consortium (Nature Medicine).
During her time at the University of California San Diego Health, Dr. Kurzrock’s charge was leading the Center for Personalized Cancer Therapy as well as the Experimental Therapeutics program, and she also founded a Rare Tumor Clinic focused on precision medicine. The signature study of the center was the IPREDICT study (Nature Medicine, 2019; Genome Medicine 2021) that gave, for the first time, individualized matched combination therapies to patients with lethal malignancies, hence resulting in improved outcomes.
Dr. Kurzrock has around 950 publications on Pubmed, an H-index of 142, and has been named to the list of most cited scientists worldwide (Web of Science) and to the list of the 25 most important voices in Precision Medicine globally.
She has four children and three dogs and lives with her husband Dr Philip Cohen, in San Diego, California.
Dr. Kurzrock is Professor of Medicine, Associate Director, Clinical Research, Linda T. and John A. Mellowes Chair of Precision Oncology, MCW Cancer Center and Linda T. and John A. Mellowes Center for Genomic Sciences and Precision Medicine, Founding Director, Michels Rare Cancers Research Laboratories, Froedtert & Medical College of Wisconsin, Adjunct Professor, University of Nebraska, USA.
Dr Kurzrock is WIN’s Chief Medical Officer, Executive Committee.
CHAIR
Jeremy Kratz, MD
Assistant Professor
Center for Precision Medicine
University of Wisconsin
View Profile
Assistant Professor
Center for Precision Medicine
University of Wisconsin
Dr. Kratz is an Assistant Professor in the Department of Medicine at the University of Wisconsin–Madison, and a basic science researcher at both the UW Center for Precision Medicine and the William S. Middleton Memorial VA Hospital. He has served as Co-Chair of UW's Precision Medicine Molecular Tumor Board, Lead for Targeted Therapeutics within the UW Carbone Cancer Center’s Clinical Therapeutics Discovery and Development Team, and a subject matter expert in gastrointestinal oncology for the VA’s National Precision Oncology Program (NPOP). As a physician-scientist, his laboratory focuses on multiple translational models of hepatobiliary and pancreatic cancer.
Toby Campbell, MD, MSCI, FAAHPM
Professor of Medicine in Oncology, Thoracic Oncologist
Chief of Palliative Care
University of Wisconsin
View Profile
Professor of Medicine in Oncology, Thoracic Oncologist
Chief of Palliative Care
Ellen and Peter O. Johnson Chair in Palliative Care
University of Wisconsin - Madison
Dr. Toby Campbell, MD, MSCI, FAAHPM is Professor of Medicine in Oncology, Thoracic Oncologist, Chief of Palliative Care and the Ellen and Peter O. Johnson Chair in Palliative Care at the University of Wisconsin - Madison. He was the HPM Fellowship Program Director from 2010 to 2017 and developed the program into a national program of excellence. Under his leadership, the UW Palliative Care Program won a Citation of Honor from the American Hospital Association’s Circle of Life program in 2017 for its innovative palliative care and the Patient and Family-Centered Care Award from the Society of Critical Care Medicine in 2019. His research interests are in high-risk shared decision-making, communication education, empathy, and models of care for palliative care implementation. His work on communication crosses a variety of disciplines and he has published in JAMA, JAMA Surgery, Annals of Surgery, Intensive Care Medicine, Patient Education and Counseling, J Pain and Symptom Management, and J of Oncology Practice to list a few. Dr. Campbell is the recipient of numerous awards related to both his research and his compassionate care for patients. Regarding research, he received the prestigious Sojourns Scholar Leadership Award from the Cambia Foundation in 2014 and Young Investigator Awards from both the American Society of Clinical Oncology and the International Association for the Study of Lung Cancer. Regarding Dr. Campbell’s clinical skills, he received recognition at each step in his career including humanism awards from the University of Virginia, University of Wisconsin, and Northwestern University. Dr. Campbell completed his undergraduate and medical degrees at the University of Virginia, where he was honored to live On The Lawn; his internal medicine residency at the University of Wisconsin; and fellowships in medical oncology and palliative medicine at Northwestern University where he also received a master’s degree in clinical investigation.